欢迎来到天天文库
浏览记录
ID:61896645
大小:866.01 KB
页数:35页
时间:2021-03-26
《胃癌辅助化疗临床试验解读.ppt》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库。
1、AdjuvantChemotherapyforGastricCancerwithS-1,anOralFluoropyrimidine--ACTS-GCIntroductionMeta-analyseshaveshownthatadjuvantchemotherapyiseffectiveintreatinggastriccancer.However,theeffectivenessofspecificregimenshasnotbeenverifiedinlargeclinicaltrials.BackgroundAdvancedgastriccancercanres
2、pondtoS-1,anoralfluoropyrimidine.WetestedS-1asadjuvantchemotherapyinpatientswithcurativelyresectedgastriccancer.METHODSPatientsinJapanwithstageIIorIIIgastriccancerwhounderwentgastrectomywithextended(D2)lymph-nodedissectionwererandomlyassignedtoundergosurgeryfollowedbyadjuvanttherapywithS
3、-1ortoundergosurgeryonly.METHODSIntheS-1group,administrationofS-1wasstartedwithin6weeksaftersurgeryandcontinuedfor1year.Thetreatmentregimenconsistedof6-weekcyclesinwhich,inprinciple,80mgoforalS-1persquaremeterofbody-surfaceareaperdaywasgivenfor4weeksandnochemotherapywasgivenforthefollowi
4、ng2weeks.Theprimaryendpointwasoverallsurvival.EligibilityCriteriaThecriteriaforeligibilitywerehistologicallyprovengastriccancerofstageII,IIIA,orIIIB;D2ormoreextensivelymph-nodedissectionwithR0surgery;nohepatic,peritoneal,ordistantmetastasis;notumorcellsinperitonealfluidoncytologicanalysi
5、s;anageof20to80years;noprevioustreatmentforcancerexceptfortheinitialgastricresectionfortheprimarylesion;andadequateorganfunction.StudyDesignandTreatmentTheprimaryendpointwasoverallsurvival;secondaryendpointswererelapse-freesurvivalandthedegreeofsafetyofS-1.Patientswereenrolled,within6wee
6、ksaftersurgeryandrandomlyassignedtoeithertheS-1grouporthesurgery-onlygroup.StudyDesignandTreatmentPatientsassignedtotheS-1groupreceivedtwooraldosesof40mgofS-1persquaremeterofbody-surfaceareaperday,for4weeks,followedby2weeksofnochemotherapy.This6-weekcyclewasrepeatedduringthefirstyearafte
7、rsurgery.Thesurgery-onlygroupreceivednoanticancertreatmentaftersurgery,unlesstherewasaconfirmedrelapse.Patientsinbothgroupsweretobefollowedupfor5yearspostoperatively.RESULTSWerandomlyassigned529patientstotheS-1groupand530patientstothesurgeryonlygroupbetweenOctober2001andD
此文档下载收益归作者所有